The Business Research Company published its Pharmaceuticals Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Pharmaceuticals market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus. The report covers the pharmaceuticals market’s segments- by type: pharmaceutical drugs, biologics, by distribution channel: hospital pharmacies, retail pharmacies/ drug stores, others, by route of administration: oral, parenteral, others, by drug classification: branded drugs, generic drugs, and by mode of purchase: prescription-based drugs, over-the-counter drugs subsegments covered: cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorders drugs, musculoskeletal disorders drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, respiratory diseases drugs, monoclonal antibodies (MAbS), therapeutic proteins, vaccines.

View Complete Report:

Pharmaceuticals Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

The global pharmaceuticals market is expected to decline from $1.22 trillion in 2019 to $1.21 trillion in 2020 at a rate of -0.7%. The decline is mainly due to the COVID-19 pandemic that has affected industries across the globe including the pharmaceutical sector. Although there has been huge demand for certain drugs (antivirals, antibiotics, respiratory drugs, anti-diabetic drugs), the restrictions on non-essential medical services, drug shortages due to slowed production of biologics and pharmaceuticals because of extended factory closures in various countries, shortage of APIs and other chemicals, and rise in prices of key ingredients have been the roadblocks obstructing the market’s growth. The market is then expected to recover and grow at a rate of 9% from 2021 and reach about $1.74 trillion in 2023.

Early Rx-to-OTC switch, or switching the product from prescription to non-prescription status, is a key trend in the dermatology drugs market. Traditionally, the Rx-to-OTC status conversion usually took place at a time nearing the patent expiry or after. However, forward-thinking companies are now looking at switching from Rx-to-OTC well in advance of the patent expiry of the drug. This helps the manufacturer to capitalize on the market opportunities for the product.

Few Points From Table Of Content
1. Executive Summary
2. Report Structure
3. Pharmaceuticals Market Characteristics
4. Pharmaceuticals Market Product Analysis
5. Pharmaceuticals Market Supply Chain
20. Pharmaceuticals Market Competitive Landscape
21. Key Mergers And Acquisitions In The Pharmaceuticals Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer

Request A Sample Report At:

Few Points From List Of Table
Table 1: Historic Market Growth, Value ($ Billion)
Table 2: Forecast Market Growth, Value ($ Billion)
Table 3: Global Pharmaceuticals Market, 2019, By Region, Value ($ Billion)
Table 153: Johnson & Johnson Financial Performance
Table 154: Merck & Co. Financial Performance
Table 155: Global Pharmaceuticals Market In 2023- Growth Countries
Table 156: Global Pharmaceuticals Market In 2023- Growth Segments
Table 157: Global Pharmaceuticals Market In 2023- Growth Strategies

About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on Blog:
Follow us on LinkedIn: